id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-N-0660-0001,FDA,FDA-2021-N-0660,Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Interoperable Automated Glycemic Controller,Rule,Final Rule,2022-03-14T04:00:00Z,2022,3,2022-03-14T04:00:00Z,,2022-03-14T13:05:39Z,2022-05303,0,0,0900006484fc63c6